Product Information
OSELTAMIVIR PHOS 30 MG CAPSULE is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.6950 per EA under NDC 76282070245. Its NADAC has been published 124 times since Apr 10, 2024.
FDA first approved this application on Oct 3, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Exelan Pharmaceuticals Inc.NDC
76282070245
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA217467FDA Approved
10/3/2023
TE Code
AB
On Market Since
12/1/2023
Pharmacological Classes
Price Statistics
The NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has been published 124 times since Apr 10, 2024, and over the history we have for it it has declined 40.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6950 per EA |
|---|---|
| All-time high | $1.1693 (Apr 10, 2024) |
| All-time low | $0.6013 (Aug 20, 2025) |
| 52-week high | $0.8323 |
| 52-week low | $0.6013 |
| Median price | $0.8295 |
| Average price | $0.8473 |
| Largest weekly change | +34.1% (Jun 19, 2024) |
| Weeks tracked | 124 |
| Tracking since | Apr 10, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the OSELTAMIVIR PHOSPHATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OSELTAMIVIR PHOS 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR PHOS 30 MG CAPSULE, manufactured by Exelan Pharmaceuticals Inc., is $0.6950 per EA (NDC 76282070245), effective Aug 19, 2026.
How has the price of OSELTAMIVIR PHOS 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has declined 40.6%. It has been tracked across 124 weekly CMS publications since Apr 10, 2024.
What are the highest and lowest recorded NADAC prices for OSELTAMIVIR PHOS 30 MG CAPSULE?
Since Apr 10, 2024, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has ranged from a low of $0.6013 (Aug 20, 2025) to a high of $1.1693 (Apr 10, 2024), with a median of $0.8295 per EA.
Are there cheaper alternatives to OSELTAMIVIR PHOS 30 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of OSELTAMIVIR PHOS 30 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OSELTAMIVIR PHOS 30 MG CAPSULE?
OSELTAMIVIR PHOS 30 MG CAPSULE (NDC 76282070245) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.